The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Body Weight, Body Fat Distribution, and Hormonal Replacement Therapy in Early Postmenopausal Women
Abstract
Body weight was measured, and body fat distribution was determined by dual energy x-ray in early postmenopausal women given either oral calcium (500 mg/day; control group; n = 12) or hormonal replacement therapy (HRT), a combination of estradiol valerate (2 mg/day for 21 days) with cyproterone acetate (1 mg/day in the last 10 days of the treatment cycle; n = 15). There were no differences in basal body weight or body fat distribution in the two groups before the study. In the control group, a significant (P < 0.05) increase in body weight (from 63.6 +/- 2.2 to 65.2 +/- 1.9 kg [corrected] after 12 months) paralleled a slight, but significant (P < 0.05), increase in total body fat mass (from 23.8 +/- 2.2 to 24.7 +/- 2.2 kg), with an increase in fat in the trunk (from 10.2 +/- 0.4 to 11.3 +/- 0.4 kg; P < 0.01) and arms (from 2.4 +/- 0.5 to 2.7 +/- 0.2 kg; P < 0.05). These findings demonstrate a shift to a prevalent central android fat distribution after 12 months of observation in untreated postmenopausal women. Conversely, in the HRT group, total body bone mineral showed a significant (from 1089 +/- 28 to 1106 +/- 29 mg/cm2; P < 0.05) increase after 12 months, with no significant increase in body weight (from 62.2 +/- 1.6 to 62.7 +/- 1.6 kg), and no modifications in trunk (from 10.0 +/- 0.2 to 9.8 +/- 0.3 kg) and arm (from 2.43 +/- 0.2 to 2.5 +/- 0.1 kg) fat, but a significant increase in leg fat (from 7.1 +/- 0.3 to 8.3 +/- 0.4 kg; P < 0.05). The present results suggest that HRT can counteract at least in part the postmenopausal increase in body weight and body fat and prevent central body fat distribution after menopause.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies generally show that estrogen replacement therapy in postmenopausal women can promote weight loss and improve metabolic markers including fat distribution, notably by increasing subcutaneous fat and reducing visceral fat mass (201–203).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [203]
In the citing paper
“In premenopausal women, oestrogens protect against weight gain by increasing energy expenditure, whereas postmenopausal women gain weight by the natural decrease in endogenous estradiol levels (Gambacciani et al., 1997).”
From Mitochondrial Activity and Dynamics Changes Regarding Metabolism in Ageing and Obesity (2017) · cites this paper as Gambacciani et al., 1997
In the citing paper
“These reductions can be prevented by oestrogen replacement therapy, indicating a direct relationship between the levels of these hormones and metabolic control and probably mitochondrial activity (Gambacciani et al., 1997).”
From Mitochondrial Activity and Dynamics Changes Regarding Metabolism in Ageing and Obesity (2017) · cites this paper as Gambacciani et al., 1997
In the citing paper
“In premenopausal women, oestrogens protect against weight gain by increasing energy expenditure, whereas postmenopausal women gain weight by the natural decrease in endogenous estradiol levels (Gambacciani et al., 1997).”
From Mitochondrial Activity and Dynamics Changes Regarding Metabolism in Ageing and Obesity (2017) · cites this paper as Gambacciani et al., 1997
Citations
Cites
Valery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320
Lapidus, L., Bengtsson, C., Larsson, B., Pennert, K. M., Rybo, E., & Sjöström, L. (1984) · BMJ · doi:10.1136/bmj.289.6454.1257 · Cited by 1,657
Mazess, R., Barden, H. S., Bisek, J., & Hanson, J. (1990) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/51.6.1106 · Cited by 1,465
EVANS, D. J., Hoffmann, R. G., Kalkhoff, R. K., & Kissebah, A. H. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-304 · Cited by 582
Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause
Haarbo, J., Marslew, U., Gotfredsen, A., & Christiansen, C. (1991) · Metabolism · doi:10.1016/0026-0495(91)90037-w · Cited by 442
Evans, D. J., Hoffman, R. G., Kalkhoff, R. K., & Kissebah, A. H. (1984) · Metabolism · doi:10.1016/0026-0495(84)90164-1 · Cited by 389
The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample
Burger, H., DUDLEY, E. C., Hopper, J. L., SHELLEY, J. M., Green, A. C., Smith, A. M. A., Dennerstein, L., & Morse, C. A. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530596 · Cited by 343
NONCONTRACEPTIVE ESTROGEN USE AND CARDIOVASCULAR DISEASE
Bush, T. L., & Barrett‐Connor, E. (1985) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036287 · Cited by 229
WAJCHENBERG, B. L., Bosco, A., Marone, M. M. S., Levin, S., Rocha, M., Lerário, A. C., Nery, M., Goldman, J., & Liberman, B. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.9.7673425 · Cited by 170
Svendsen, O. L., Hassager, C., Bergmann, I., & Christiansen, C. (1993) · PubMed · Cited by 163
Cited by
Sorted by citations
Items 301–319 of 319
Obesity and Osteoporosis: Is the Paradigm Changing?
Greco, E. A., Fornari, R., Lenzi, A., & Migliaccio, S. (2018) · Springer eBooks · doi:10.1007/978-3-319-75110-8_9
Gambacciani, M. (2018) · Journal of Endocrinology and Thyroid Research · doi:10.19080/jetr.2018.03.555611
Self-citationIncremento Ponderale e Modificazioni del Metabolismo Glucidico
Cagnacci, A., Zanin, R., Caretto, S., Toni, A. D., Cannoletta, M., & Volpe, A. (2008) · IRIS UNIMORE (University of Modena and Reggio Emilia)
Wang, J., Zhu, B., Jin, X., Chen, K., Yan, W., Wang, A., Wang, W., Gao, Z., Tang, X., Li, Y., et al. (2020) · doi:10.21203/rs.3.rs-28851/v1
Cardiovascular Impact of Metabolic Abnormalities
Tsiligiannis, S., & Stevenson, J. C. (2021) · ISGE series · doi:10.1007/978-3-030-63650-0_17
DHEA, Obesity and Cardiovascular Disease
Tchernof, A., Labrie, F., & Després, J. (2011) · De Gruyter eBooks · doi:10.1515/9783110811162.191
Wirkungen und Stoffwechsel der wichtigsten natürlichen Sexualsteroide der Frau
Gudermann, T. W., & Leidenberger, F. A. (2005) · Springer eBooks · doi:10.1007/3-540-26406-x_2
(2005) · Obesity Management · doi:10.1089/obe.2005.1.160
El-Kaream, S. A. A., Abdel-Monem, S. M., Khalil, G. I., & Mostafa, H. (2015) · American Journal of Biomedical Sciences · doi:10.5099/aj150200063
Menopausa e fatores de risco associados a doença cardiovascular
Raskin, D. B. F. (2005) · doi:10.47749/t/unicamp.2005.336975
Avaliação de dimorfismo sexual na regulação central do metabolismo energético de camundongos.
de Souza, G. O. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2020.tde-13012022-220345
Origins and consequences of altered metabolic processes in obese pregnant women
Barr, S. M. (2013) · ERA
Christakoudi, S., Tsilidis, K. K., Evangelou, E., & Riboli, E. (2021) · Figshare · doi:10.6084/m9.figshare.16821598
Zhang, H., Zhang, Y., Gao, W., & Mu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.25271851
Metabolic disorders: Sex and gender evidence in dyslipidemia, diabetes, and obesity
Newman, C. B., Saunders, K. H., Schmitz, S. H., & Subramanian, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-26712-3.00020-3
The Role of Antiandrogens in Peri- and Postmenopausal HRT
Schneider, H. P. G. (2002) · Medical science symposia series · doi:10.1007/978-1-4615-1061-1_11
Etude du rôle des sous-populations monocytaires dans l'obésité et l'insulinorésistance
Béliard, S. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique)
Study of women veterans in menopause
Rouen, P. A. (2009) · Deep Blue (University of Michigan)
Metadata
- Authors
- Gambacciani, M., Ciaponi, M., Cappagli, B., Piaggesi, L., De Simone, L., Orlandi, R., & Genazzani, A. R.
- Affiliations
- University of Pisa (IT)
- Corresponding author
- Gambacciani, M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1997-02
- Volume
- 82
- Issue
- 2
- Pages
- 414-417
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2063248917
- Cited by
- 321
- References
- 27
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 9 · 2023: 6 · 2022: 8 · 2021: 11 · 2020: 10 · 2019: 7 · 2018: 13 · 2017: 8 · 2016: 9 · 2015: 12 · 2014: 8 · 2013: 16 · 2012: 11
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- postmenopausal women, body weight, body fat distribution, abdominal obesity, android fat, estradiol valerate, cyproterone acetate, bone mineral density, calcium supplementation, leg fat, trunk fat, arm fat, menopause, osteoporosis prevention, dual-energy X-ray absorptiometry, body composition changes
- MeSH terms
- Adipose Tissue, Body Composition, Body Weight, Calcium, Female, Humans, Middle Aged, Reference Values, Estrogen Replacement Therapy, Postmenopause
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review